Search clinical trials for: Machine learning algorithm

Total 10000 results

Janssen Research & Development, LLC

Completed

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older (Engage)

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, Belgium, Canada, Poland
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

Intestinal Health

United States
Fondazione Policlinico Universitario Campus Bio-Medico
OM Pharma SA

Active, not recruiting

OM 85 to Prevent Respiratory Infections in Older At Risk Patients (OM85OLDER)

Respiratory Tract Infections (RTI)

Italy
PT Bio Farma
Center for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... and other collaborators

Completed

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

Vaccine Adverse Reaction | Vaccine Reaction

Indonesia
Chiang Mai University
Faculty of Medicine, Chiang Mai University

Completed

Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents (HAV-RCT)

Hepatitis A | Vaccine-Preventable Diseases | Hep A | HAV

Thailand
Bavarian Nordic

Active, not recruiting

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Chikungunya Virus Infection

United States
CuraSen Therapeutics, Inc.

Withdrawn

A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)

Freezing of Gait Symptoms in Parkinson's Disease

Australia
Argorna Pharmaceuticals Co., LTD

Completed

Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster

SARS-CoV-2

China
Washington University School of Medicine

No longer available

Expanded Access Neoantigen Vaccine in Solid Tumors

Solid Tumor, Adult

United States
Redx Pharma Plc
Simbec Research

Completed

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Liver Diseases | Fibrosis | Kidney Diseases | Inflammation | Idiopathic Pulmonary Fibrosis | Non-alcoholic Steatohepatitis

United Kingdom
PT Bio Farma
National Advisory Immunization Committee Indonesia

Completed

Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

COVID-19

Indonesia
Kallyope Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

Obesity | Type 2 Diabetes Mellitus in Obese

United States
Nemours Children's Health System
National Institute of General Medical Sciences (NIGMS); University of Delaware and other collaborators

Completed

Improving COVID-19 Vaccine Uptake Among Black and Latino Youth

COVID-19

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Jenna Smith
Canadian Cancer Society (CCS)

Completed

Connecting Breast Cancer Survivors for Exercise (C4E)

Breast Cancer | Breast Neoplasms

Canada
Pfizer

Completed

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

Clostridium Difficile Associated Disease

United States
Sanaria Inc.
Fred Hutchinson Cancer Center

Completed

Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults

Malaria

United States
University of Massachusetts, Worcester
National Library of Medicine (NLM)

Completed

Views on COVID-19 and Vaccination

Covid19

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

United States, Australia, New Zealand
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

HIV Infections

United States
ViiV Healthcare

Completed

A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults

HIV Infections

Spain, France, United States, Germany, Italy, South Africa
Baylor College of Medicine

Completed

Entolimod, an Adjuvant for Vaccine Augmentation

Substance Use Disorders

United States
GlaxoSmithKline

Completed

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Influenza

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Influenza

United States, Canada
GlaxoSmithKline

Completed

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

Influenza

Russian Federation, Germany, France, Greece, United Kingdom, Norway, Estonia
Rockefeller University

Completed

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

Hepatitis B

United States
KEMRI-Wellcome Trust Collaborative Research Program
University of Colorado, Denver; GlaxoSmithKline; University of Oxford; Kenya Ministry...

Unknown

PCV10 Reactogenicity and Immunogenicity Study - Malindi (PRISM)

Pneumococcal Pneumonia

Kenya
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
National Institute of Allergy and Infectious Diseases...

Completed

VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...

Influenza, Human

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Hemorrhagic Fever, Ebola

United States
Shenzhen Kangtai Biological Products Co., LTD
Guangdong Provincial Institute of Biological Products And Materia Medica

Unknown

Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates

Liver Diseases | Digestive System Diseases | Hepatitis B | Hepatitis

China
University of Oxford
European and Developing Countries Clinical Trials Partnership (EDCTP)

Completed

A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso

Malaria

Burkina Faso
Oslo University Hospital

Completed

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Glioblastoma | Brain Tumor
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
Merck Sharp & Dohme LLC

Completed

Consistency Lots Vaccine Study (V260-009)

Rotavirus Infections
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Open Angle Glaucoma or Ocular Hypertension

Japan
Jiangsu Province Centers for Disease Control and...

Completed

Safety of H1N1 Influenza Vaccination in Pregnant Women

Virus Diseases | Respiratory Tract Infections | Influenza | Orthomyxoviridae Infections

China
National Institute of Allergy and Infectious Diseases...

Completed

EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Plasmodium Falciparum Malaria

Ghana
CAMC Health System

Unknown

Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)

MRSA - Methicillin Resistant Staphylococcus Aureus Infection

United States
Sanofi

Completed

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Japanese Encephalitis

India
University College, London
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

CMV Glycoprotein B Vaccine in Allograft Recipients

Cytomegalovirus Infections

United Kingdom
PETHEMA Foundation

Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Spain
Mansoura University

Active, not recruiting

Evaluation of Patient Satisfaction After the Construction of Maxillary Obturator Prosthesis for Limited Mouth Opening in Maxillofacial Cases : Cross Over Randomized Clinical Trial

Patient Satisfaction | Maxilofacial

Egypt
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Task Force; Ural Federal University and other collaborators

Completed

Plasmonic Nanophotothermal Therapy of Atherosclerosis (NANOM-FIM)

Heart Failure | Atherosclerosis | Stable Angina | Multivessel Coronary Artery Disease

Netherlands, Russian Federation
Oxford Brookes University

Unknown

Aerosol Particle Size and Breathing Pattern During Inhaled Furosemide (FurAH-II)

Healthy Volunteers

United Kingdom
Oncolytics Biotech

Completed

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation

Carcinoma, Non-small Cell Lung

United States
Oncolytics Biotech

Completed

Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

Carcinoma, Squamous Cell of the Head and Neck

United States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
University of Wisconsin, Madison
National Eye Institute (NEI)

Recruiting

Moderators and Mediators of Perceptual Learning

Cognitive Change

United States

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations